Product Details

Auro-Ciprofloxacin

Ciprofloxacin
750 mg
Tablet


DIN/PIN/NPN

02381931

Manufacturer

Auro Pharma Inc.

Formulary Listing Date

2012-08-27  

Unit Price

0.9201

Amount MOH Pays

0.9201

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Ciprofloxacin: Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children <18 years of age. Ciprofloxacin inhibits theophylline clearance and also affects phenytoin kinetics. Theophylline doses should be decreased and blood levels of phenytoin or theophylline monitored when either of these drugs is used concomitantly with ciprofloxacin.

ATC Code

J01MA02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02379643 Septa-Ciprofloxacin 0.9201 0.9201
02248758 Sandoz Ciprofloxacin 0.9201 0.9201
02246827 Ratio-Ciprofloxacin 0.9201 0.9201
02303744 Ran-Ciproflox 0.9201 0.9201
02248439 PMS-Ciprofloxacin 0.9201 0.9201
02423588 Mint-Ciproflox 0.9201 0.9201
02379708 Mar-Ciprofloxacin 0.9201 0.9201
02380374 Jamp-Ciprofloxacin 0.9201 0.9201
02247341 Co Ciprofloxacin 0.9201 0.9201
02155974 Cipro NA NA
02381931 Auro-Ciprofloxacin 0.9201 0.9201
02229523 Apo-Ciproflox 0.9201 0.9201
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph